Cargando…
New molecular targets against cervical cancer
Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth leading cause of cancer death in women. Major advances but still insufficient achievements in the treatment of locally advanced and high-risk early stage patients have occurred in the last decade with the incorporat...
Autores principales: | Duenas-Gonzalez, Alfonso, Serrano-Olvera, Alberto, Cetina, Lucely, Coronel, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266260/ https://www.ncbi.nlm.nih.gov/pubmed/25525394 http://dx.doi.org/10.2147/IJWH.S49471 |
Ejemplares similares
-
Radiosensitizers in cervical cancer. Cisplatin and beyond
por: Candelaria, Myrna, et al.
Publicado: (2006) -
Epigenetics of cervical cancer. An overview and therapeutic perspectives
por: Dueñas-González, Alfonso, et al.
Publicado: (2005) -
Radiation-sparing managements for cervical cancer: a developing countries perspective
por: Candelaria, Myrna, et al.
Publicado: (2006) -
Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients
por: Cetina, Lucely, et al.
Publicado: (2009) -
HER2 expression in cervical cancer as a potential therapeutic target
por: Chavez-Blanco, Alma, et al.
Publicado: (2004)